Wells Fargo & Company Astrazeneca PLC Transaction History

Wells Fargo & Company

$433 Billion
Q4 2024

A detailed history of Wells Fargo & Company transactions in Astrazeneca PLC stock. As of the latest transaction made, Wells Fargo & Company holds 3,210,694 shares of AZN stock, worth $242 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

3,210,694

Previous 3,378,762 4.97%

Holding current value

$242 Million

Previous $263 Million 20.1%

% of portfolio

0.05%

Previous 0.06%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	SELL	$63.2 - $79.58 $10.6 Million - $13.4 Million	-168,068 Reduced 4.97%	3,210,694 $210 Million
Q3 2024 Nov 13, 2024	SELL	$76.67 - $87.62 $23.6 Million - $27 Million	-308,122 Reduced 8.36%	3,378,762 $263 Million
Q2 2024 Aug 13, 2024	BUY	$66.81 - $80.83 $39 Million - $47.2 Million	583,498 Added 18.8%	3,686,884 $288 Million
Q1 2024 May 10, 2024	BUY	$61.03 - $69.57 $3.54 Million - $4.03 Million	57,992 Added 1.9%	3,103,386 $210 Million
Q4 2023 Feb 09, 2024	BUY	$61.89 - $69.28 $12.7 Million - $14.2 Million	204,804 Added 7.21%	3,045,394 $205 Million
Q3 2023 Nov 13, 2023	BUY	$64.85 - $71.7 $6.25 Million - $6.9 Million	96,301 Added 3.51%	2,840,590 $192 Million
Q2 2023 Aug 15, 2023	SELL	$69.91 - $75.81 $997,056 - $1.08 Million	-14,262 Reduced 0.52%	2,744,289 $196 Million
Q1 2023 May 12, 2023	BUY	$63.15 - $71.6 $30 Million - $34 Million	475,061 Added 20.8%	2,758,551 $191 Million
Q4 2022 Feb 13, 2023	SELL	$54.21 - $70.44 $5.53 Million - $7.19 Million	-102,080 Reduced 4.28%	2,283,490 $155 Million
Q3 2022 Nov 14, 2022	BUY	$53.02 - $135.75 $1.54 Million - $3.95 Million	29,112 Added 1.24%	2,385,570 $131 Million
Q2 2022 Aug 12, 2022	BUY	$59.26 - $71.14 $3.75 Million - $4.5 Million	63,294 Added 2.76%	2,356,458 $156 Million
Q1 2022 May 16, 2022	BUY	$55.72 - $67.12 $41 Million - $49.4 Million	736,076 Added 47.27%	2,293,164 $152 Million
Q4 2021 Feb 14, 2022	BUY	$54.02 - $63.83 $970,847 - $1.15 Million	17,972 Added 1.17%	1,557,088 $90.7 Million
Q3 2021 Nov 15, 2021	BUY	$55.56 - $60.79 $8.66 Million - $9.47 Million	155,846 Added 11.27%	1,539,116 $92.4 Million
Q2 2021 Aug 16, 2021	SELL	$48.42 - $60.18 $12.9 Million - $16 Million	-265,675 Reduced 16.11%	1,383,270 $82.9 Million
Q1 2021 May 13, 2021	SELL	$47.16 - $54.44 $12.5 Million - $14.4 Million	-264,962 Reduced 13.84%	1,648,945 $82 Million
Q4 2020 Feb 09, 2021	SELL	$48.52 - $58.02 $23.9 Million - $28.6 Million	-493,289 Reduced 20.49%	1,913,907 $95.7 Million
Q3 2020 Nov 05, 2020	BUY	$53.07 - $61.1 $9.52 Million - $11 Million	179,432 Added 8.05%	2,407,196 $132 Million
Q2 2020 Aug 13, 2020	BUY	$43.1 - $55.31 $4.95 Million - $6.36 Million	114,926 Added 5.44%	2,227,764 $118 Million
Q1 2020 May 14, 2020	BUY	$37.79 - $51.33 $79.8 Million - $108 Million	2,112,838 New	2,112,838 $94.4 Million

Others Institutions Holding AZN

# of Institutions

1,358

Shares Held

512M

Call Options Held

6.08M

Put Options Held

4.44M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $234B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Astrazeneca PLC Transaction History